We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$405M
AUM Growth
+$20.1M
Cap. Flow
-$7.46M
Cap. Flow %
-1.84%
Top 10 Hldgs %
74.32%
Holding
24
New
4
Increased
1
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$23.3M
2
GH icon
Guardant Health
GH
+$9.47M
3
BBIO icon
BridgeBio Pharma
BBIO
+$9.43M
4
SRRK icon
Scholar Rock
SRRK
+$8.46M
5
ARGX icon
argenx
ARGX
+$1.42M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$12.9M
2
ASND icon
Ascendis Pharma A/S
ASND
+$8.81M
3
EXAS
Exact Sciences
EXAS
+$8.38M
4
NTRA icon
Natera
NTRA
+$6.83M
5
TMDX icon
Transmedics
TMDX
+$6.77M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$29.4B
$43.1M 10.65%
428,600
-14,700
-3% -$1.12M
ARGX icon
2
argenx
ARGX
$54.2B
$42.7M 10.53%
77,430
+2,440
+3% +$1.42M
NTRA icon
3
Natera
NTRA
$45.9B
$39.9M 9.84%
235,964
-43,800
-16% -$6.83M
ILMN icon
4
Illumina
ILMN
$29B
$32.8M 8.09%
343,361
– –
ICLR icon
5
Icon
ICLR
$12.8B
$29.5M 7.28%
202,790
-6,400
-3% -$908K
NBIX icon
6
Neurocrine Biosciences
NBIX
$16.8B
$27.3M 6.74%
217,200
-7,900
-4% -$906K
DXCM icon
7
DexCom
DXCM
$33.1B
$23.9M 5.9%
273,821
-83,100
-23% -$6.51M
RARE icon
8
Ultragenyx Pharmaceutical
RARE
$2.64B
$22.8M 5.63%
627,600
– –
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$13.3B
$20.2M 4.98%
366,812
-15,800
-4% -$930K
UNH icon
10
UnitedHealth
UNH
$371B
$19M 4.69%
+60,888
New +$23.3M
PRCT icon
11
Procept Biorobotics
PRCT
$1.24B
$17.2M 4.25%
299,089
– –
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$29B
$15M 3.71%
46,086
-19,570
-30% -$5.42M
AKRO
13
DELISTED
Akero Therapeutics
AKRO
$12.1M 2.98%
226,400
– –
EXAS
14
DELISTED
Exact Sciences
EXAS
$11.9M 2.93%
223,750
-164,900
-42% -$8.38M
BBIO icon
15
BridgeBio Pharma
BBIO
$16.6B
$11.2M 2.76%
+259,300
New +$9.43M
GH icon
16
Guardant Health
GH
$22.4B
$11M 2.72%
+212,000
New +$9.47M
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.95B
$11M 2.72%
330,830
– –
SRRK icon
18
Scholar Rock
SRRK
$6.32B
$9.54M 2.36%
+269,400
New +$8.46M
ISRG icon
19
Intuitive Surgical
ISRG
$139B
$2.39M 0.59%
4,390
– –
IMCR icon
20
Immunocore
IMCR
$1.73B
$1.45M 0.36%
46,300
– –
VIR icon
21
Vir Biotechnology
VIR
$1.5B
$1.21M 0.3%
240,500
– –
ASND icon
22
Ascendis Pharma A/S
ASND
$16.8B
– –
-56,500
Closed -$8.81M
INSP icon
23
Inspire Medical Systems
INSP
$1.73B
– –
-81,121
Closed -$12.9M
TMDX icon
24
Transmedics
TMDX
$3.07B
– –
-100,661
Closed -$6.77M

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Eagle Health Investments's Q2 2025 Portfolio in Review

As of Q2 2025, Eagle Health Investments held 24 positions worth $405M, up 5.2% from $385M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Eagle Health Investments's Q2 2025 filing shows 4 new, 1 increased, 8 reduced and 3 closed positions. Its largest new stake was UnitedHealth: 60,888 shares worth $19M. The largest sale was Inspire Medical Systems, an estimated $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Eagle Health Investments's largest Q2 2025 buy was UnitedHealth: 60,888 shares worth $19M.
  • Eagle Health Investments added most to argenx in Q2 2025, an estimated $1.42M increase.
  • Eagle Health Investments's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $8.38M.
  • Eagle Health Investments fully exited Inspire Medical Systems in Q2 2025, selling an estimated $12.9M.
  • Eagle Health Investments's ten largest holdings make up 74% of its $405M portfolio in Q2 2025.
  • Eagle Health Investments opened 4 new positions and closed 3 in Q2 2025.
  • Eagle Health Investments's portfolio value rose 5.2% quarter-over-quarter to $405M.

Based on Eagle Health Investments's 13F filing for Q2 2025, filed 12 Aug 2025.